Hemofiltration for Contrast-Induced Nephropathy

NCT00158080 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2005-09-12

No results posted yet for this study

Summary

Contrast-induced acute renal failure can be prevented with hemofiltration which is performed during cardiac catheterization

Conditions

Interventions

PROCEDURE

hemofiltration

Sponsors & Collaborators

  • Nara Medical University

    lead OTHER

Principal Investigators

  • Yoshihiko Saito, MD, PhD · Nara Medical University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00158080 on ClinicalTrials.gov